MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

Search

Quidel Corp

Fechado

15.86 -8.38

Visão Geral

Variação de preço das ações

24h

Atual

Mín

15.7

Máximo

17.21

Indicadores-chave

By Trading Economics

Rendimento

602M

-131M

Vendas

24M

724M

Margem de lucro

-18.062

Funcionários

6,500

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+78.26% upside

Dividendos

By Dow Jones

Próximos Ganhos

6 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-310M

899M

Abertura anterior

24.24

Fecho anterior

15.86

Quidel Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

6 de abr. de 2026, 23:17 UTC

Ganhos

Samsung Forecasts Record First-Quarter Operating Profit

6 de abr. de 2026, 23:00 UTC

Ações em Alta

Stocks to Watch: Health Insurers, Mawson, Owlet

6 de abr. de 2026, 22:13 UTC

Grandes Movimentos do Mercado

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 de abr. de 2026, 21:46 UTC

Aquisições, Fusões, Aquisições de Empresas

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 de abr. de 2026, 17:09 UTC

Grandes Movimentos do Mercado

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 de abr. de 2026, 16:56 UTC

Notícias Principais

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 de abr. de 2026, 14:47 UTC

Grandes Movimentos do Mercado

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 de abr. de 2026, 00:00 UTC

Notícias Principais

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 de abr. de 2026, 23:58 UTC

Conversa de Mercado
Notícias Principais

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 de abr. de 2026, 23:50 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 de abr. de 2026, 23:36 UTC

Conversa de Mercado

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 de abr. de 2026, 23:15 UTC

Conversa de Mercado

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 de abr. de 2026, 22:52 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

6 de abr. de 2026, 22:52 UTC

Conversa de Mercado

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 de abr. de 2026, 22:14 UTC

Conversa de Mercado

Correction to Live Cattle Futures Article

6 de abr. de 2026, 20:56 UTC

Conversa de Mercado

Mexican Private Consumption Fell in January -- Market Talk

6 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Energy & Utilities Roundup: Market Talk

6 de abr. de 2026, 20:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

6 de abr. de 2026, 19:58 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

6 de abr. de 2026, 19:58 UTC

Conversa de Mercado

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 de abr. de 2026, 19:11 UTC

Conversa de Mercado

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 de abr. de 2026, 19:06 UTC

Conversa de Mercado

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 de abr. de 2026, 19:03 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

6 de abr. de 2026, 19:03 UTC

Conversa de Mercado

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 de abr. de 2026, 18:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 de abr. de 2026, 17:59 UTC

Conversa de Mercado
Notícias Principais

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 de abr. de 2026, 17:13 UTC

Aquisições, Fusões, Aquisições de Empresas

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 de abr. de 2026, 16:33 UTC

Conversa de Mercado

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 de abr. de 2026, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

6 de abr. de 2026, 14:59 UTC

Ganhos

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Comparação entre Pares

Variação de preço

Quidel Corp Previsão

Preço-alvo

By TipRanks

78.26% parte superior

Previsão para 12 meses

Média 30.75 USD  78.26%

Máximo 38 USD

Mínimo 25 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Quidel Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

5 ratings

1

Comprar

3

Manter

1

Vender

Informação Financeira

Custos administrativos e de venda

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

Resultado Operacional

$

Sobre Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat